Delineation of the vitreous and posterior hyaloid using bromophenol blue

Retina

Volumn 28, Issue 2, 2008, Pages 333-339

  Haritoglou, Christos ^a   Strauss, Rupert ^a   Priglinger, Siegfried G ^a   Kreutzer, Thomas ^a   Kampik, Anselm ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bromophenol blue; Vital dyes; Vitrectomy; Vitreous staining

Indexed keywords

BROMOPHENOL BLUE; FLUOROCARBON; COLORING AGENT; DIAGNOSTIC AGENT; HEXAFLUOROETHANE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INTRAOCULAR PRESSURE; MALE; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; RETINA DETACHMENT; RETINA MACULA HOLE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; MEMBRANE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RETINA TEAR; VITREOUS BODY;

AGED; BROMPHENOL BLUE; COLORING AGENTS; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FLUOROCARBONS; HUMANS; INTRAOCULAR PRESSURE; MALE; MEMBRANES; MIDDLE AGED; PERIMETRY; RETINAL DETACHMENT; RETINAL PERFORATIONS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 42449115822     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31814fb0ff     Document Type: Article

References (31)

1. Yoshida M, Kishi S. Pathogenesis of macular hole recurrence and its prevention by internal limiting membrane peeling. Retina 2007;27:169-173.
2. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
3. Tognetto D, Grandin R, Sanguinetti G, et al. Macular Hole Surgery Study Group. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 2006;113:1401-1410.
4. Haritoglou C, Gandorfer A, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841.
5. Haritoglou C, Gandorfer A, Gass CA, et al. The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 2003;135:328-337.
6. Kanda S, Uemura A, Yamashita T, et al. Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 2004;122:1447-1451.
7. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014.
8. Da Mata AP, Burk SE, Foster RE, et al. Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair. Ophthalmology 2004;111:2246-2253.
9. Haritoglou C, Gandorfer A, Schaumberger M, et al. Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome. Retina 2004;24:582-590.
10. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, et al. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-144.
11. Nishimura M, Ikeda T, Ushiyama M, et al. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production. Clin Sci (Lond) 2000;98:9-14.
12. Rodrigues EB, Meyer CH, Kroll P. Chromovitrectomy: a new field in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2005;243:291-293.
13. Horobin RW, Kiernan JA, eds. Conns Biological Stains. 10th ed. Oxford, UK: BIOS Scientific Publishers, Ltd; 2002:216.
14. Haritoglou C, Yu A, Freyer W, et al. An evaluation of novel vital dyes for intraocular surgery. Invest Ophthalmol Vis Sci 2005;46:3315-3322.
15. Schuettauf F, Haritoglou C, May CA, et al. Administration of novel dyes for intraocular surgery: an in vivo toxicity animal study. Invest Ophthalmol Vis Sci 2006;47:3573-3578.
16. Haritoglou C, Tadayoni R, May CA, et al. Short-term in vivo evaluation of novel vital dyes for intraocular surgery. Retina 2006;26:673-678.
17. Haritoglou C, Schumann R, Strauss R, et al. Vitreoretinal surgery using bromophenol blue as a vital stain: evaluation of staining characteristics in humans. Br J Ophthalmol 2007;[Epub ahead of print].
18. Sebag J, Hageman GS. Interfaces. Rome: Fondazione G.B. Bietti, Per lo Studio e la Ricerca in Oftalmologio; 2000:55.
19. Gass DJ. Idiopathic senile macular holes. Its early stages and pathogenesis. Arch Ophthalmol 1988;106:629-639.
20. Tadayoni R, Gaudric A, Haouchine B, Massin P. Relationship between macular hole size and the potential benefit of internal limiting membrane peeling. Br J Ophthalmol 2006;90:1239-1241.
21. Matsumoto H, Yamanaka I, Hisatomi T, et al. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane. Retina 2007;27:174-179.
22. Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000;20:554-555.
23. Doi N, Uemura A, Nakao K, Sakamoto T. Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina 2005;25:742-745.
24. Tognetto D, Zenoni S, Sanguinetti G, et al. Staining of the internal limiting membrane with intravitreal triamcinolone acetonide. Retina 2005;25:462-467.
25. Yamauchi Y, Nakamura H, Hayakawa K, Sawaguchi S. Persistence of triamcinolone acetonide following macular hole surgery. Acta Ophthalmol Scand 2006;84:711-712.
26. Kozak I, Cheng L, Mendez T, et al. Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 2006;26:811-817.
27. Sonoda KH, Enaida H, Ueno A, et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 2003;87:1010-1014.
28. Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 2002;240:423-429.
29. Jackson TL, Griffin L, Vote B, et al. An experimental method for testing novel retinal vital stains. Exp Eye Res 2005;81:446-454.
30. Enaida H, Hisatomi T, Goto Y, et al. Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 2006;26:623-630.
31. Enaida H, Hisatomi T, Hata Y, et al. Brilliant blue G selectively stains the internal limiting membrane: brilliant blue G-assisted membrane peeling. Retina 2006;26:631-636.